Loading...
•
Dec 31, 2022
CareDx Q4 2022 Earnings Report
CareDx reported Q4 2022 results with revenue increase and strategic focus on key initiatives.
Key Takeaways
CareDx reported a 4% increase in revenue for Q4 2022, reaching $82.4 million. The company focused on key initiatives such as improving cash collections and expanding coverage, while also managing a net loss and adjusted EBITDA loss for the quarter.
Achieved Q4 revenue of $82.4 million, a 4% increase year-over-year.
Provided approximately 47,700 AlloMap and AlloSure patient results in Q4, growing 14% year-over-year.
Achieved highest ever cash collections in Q4 at 110% of revenue for testing services.
Commenced authorized share buyback program of up to $50 million, repurchasing approximately $0.6 million in Q4.
Revenue by Segment
Forward Guidance
CareDx expects revenue to be in the range of $328 million to $338 million for the full year 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...